ArticleJournal of hepatocellular carcinoma2023

Hepatic Arterial Infusion Chemotherapy Plus Lenvatinib and Tislelizumab with or Without Transhepatic Arterial Embolization for Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombus and High Tumor Burden: A Multicenter Retrospective Study.

Song Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.